Sclérothérapie dans les hémorragies gastrointestinales

Soehendra, Nib; Grimm, Hanna; Kempeneers, I.

doi:10.1007/bf02966224

Cited by 4 publications

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The sclerosant polidocanol has been used immediately following epinephrine injection. Soehendra and coworkers [42] reported permanent hemostasis in 84% of pulsatile bleeding and 92% of oozing lesions, mostly ulcers, so treated. In a controlled series using a similar regimen in 113 patients, Panes and associates [43] reported that the treatment group experienced major rebleeding less often (5.5% vs. 25% in conventionally treated controls), required fewer urgent operations (5% vs. 34%), and had a lower transfusion requirement, but no significant difference in mortality (4% and 7%).…”

Section: Injection Methodsmentioning

confidence: 99%

Endoscopic management of nonvariceal gastrointestinal bleeding

Steffes

Sugawa

1992

World j. surg.

View full text Add to dashboard Cite

Endoscopic management of upper gastrointestinal bleeding has been expanded from a purely diagnostic role to a therapeutic role in many patients. In addition to controlling active bleeding, it is an option in a patient who is clinically at a high risk of rebleeding, or in patients who have peptic ulcers with visible vessels or stigmata indicating high risk. Several methods have been studied, and currently the most useful include thermal cautery with the heater probe or bipolar electrocoagulation, and injection using epinephrine and/or sclerosants. Endoscopic hemostasis can effect permanent control of bleeding in many patients, but should be considered complementary to conventional surgical control in other patients, where temporary control to stabilize the patient is a desired end.

show abstract

Section: Injection Methodsmentioning

confidence: 99%